(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

RISKREVEAL

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

RISKREVEAL

ST13

US500000098892801

Class

44

Filing

98892801

Registration

7904890

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

9

Latest update

06/25/2026

Trademark type

Word

Nice classes

44

Filing date

12/09/2024

Registration date

08/19/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/19/2025

Last transaction

06/25/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

02/16/2023

First use in commerce

02/16/2023

Drawing code

4

Owner type

03

Owner location

Nashville, TN, US

Examiner

HOPKINS II, DEAN ANDREW

Law office

N50

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

RAZOR GENOMICS, INC.

Representatives

DAVID R. STEVENS STEVENS LAW GROUP

Technical classification

Nice Classes

Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 44

Medical testing for diagnostic or treatment purposes; Medical diagnostic testing for analysis of tumor tissue in the field of oncology; Medical molecular diagnostic testing for analysis of tumor tissue in the field of oncology; Medical prognostic testing for analysis of tumor tissue in the field of oncology; Medical molecular prognostic testing for analysis of tumor tissue in the field of oncology; Medical diagnostic molecular treatment stratification testing for analysis of tumor tissue in the field of oncology; Medical prognostic molecular treatment stratification testing for analysis of tumor tissue in the field of oncology; Medical testing of tumor tissue for use in risk segregation and managing disease treatmentcancer.

Publications

History of USPTO decisions and trademark events.

9 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

08/19/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

08/19/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/01/2025

PUBO

PUBLISHED FOR OPPOSITION

07/01/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/25/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/31/2025

DOCK

ASSIGNED TO EXAMINER

05/28/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/19/2025

NWAP

NEW APPLICATION ENTERED

12/09/2024

Continuous trademark protection

Get notified about every new filing that threatens RISKREVEAL or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.